The association between depression and isotretinoin use in acne

Australian and New Zealand Journal of Psychiatry

Volumn 37, Issue 1, 2003, Pages 78-84

  Ng, Chee Hong ^a   Schweitzer, Isaac ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Acne; Depression; Isotretinoin; Suicide

Indexed keywords

ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; ISOTRETINOIN; ORATANE; TOPICAL AGENT;

ACNE; ARTICLE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; DRY SKIN; DYSLIPIDEMIA; HUMAN; LETHARGY; LIVER TOXICITY; MALE; MEDICAL LITERATURE; NONHUMAN; PATIENT REFERRAL; PHOTOSENSITIVITY; PREDICTION; PSYCHOSIS; PSYCHOSOCIAL WITHDRAWAL; SUICIDAL BEHAVIOR;

ACNE VULGARIS; ADOLESCENT; DEPRESSION; HUMANS; ISOTRETINOIN; KERATOLYTIC AGENTS; MALE;

EID: 0037303674     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2003.01111.x     Document Type: Article

References (38)

1. Josefson D. Acne drug linked to severe depression. British Medical Journal 1998; 316:723.
2. Nguyen EH, Wolverton SE. Systemic retinoids. In: Wolverton SE, ed. Comprehensive dermatologic drug therapy. Philadelphia: Saunders, 2001; 269-310.
3. Farrell LN, Strauss JS, Stranieri AM. The treatment of severe cystic acne with 13-cis-retinoic acid: evaluation of sebum production and the clinical response in a multiple-dose trial. Journal of the American Academy of Dermatology 1980; 3:602-611.
4. Mills CM, Marks R. Adverse reactions to oral retinoids. Drug Safety 1993; 9:280-290.
5. Bigby M, Stern RS. Adverse reactions to isotretinoin. Journal of the American Academy of Dermatology 1988; 18:543-552.
6. Hull PR, Demkiw-Bartel C. Isotretinoin use in acne: prospective evaluation of adverse events. Journal of Cutaneous Medicine and Surgery 2000; 4:66-70.
7. Lamberg L. Acne drug depression warnings highlight need for expert care. Journal of the American Medical Association 1998; 279:1073.
8. Byrne A, Hnatko G. Depression associated with isotretinoin therapy. Canadian Journal of Psychiatry 1995; 40:567.
9. Duke E, Guenther L. Psychiatric reactions to the retinoids. Canadian Journal of Dermatology 1993; 5:467.
10. Bravard P, Krug M, Rzeznick JC. Isotretinoin et depressoin, soyons vigilantes. Nouveau Dermatologie 1993; 12:215.
11. Gatti S, Serri F. Acute depression from isotretinoin. Journal of the American Academy of Dermatology 1991; 25:132.
12. Ng CH, Tam MM, Hook SJ. Acne, isotretinoin treatment and acute depression. World Journal of Biological Psychiatry 2001; 2:159-161.
13. Ault A. Isotretinoin use may be linked with depression. Lancet 1998; 351:730.
14. Scheinman PL, Peck GL, Rubinow DR, DiGiovanna JJ, Abangan DL, Ravin PD. Acute depression from isotretinoin. Journal of the American Academy of Dermatology 1990; 22:1112-1114.
15. Hazen PG, Carney JF, Walker AE, Stewart JJ. Depression - a side effect of 13-cis-retinoic acid therapy. Journal of the American Academy of Dermatology 1983; 9:278-279.
16. Goulden V, Layton AM, Cunliffe WJ. Long-term safety of isotretinoin in the treatment of acne vulgaris. British Journal of Dermatology 1994; 131:360-363.
17. Adverse Drug Reactions Advisory Committee (ADRAC). Depression and isotretinoin. Australian Adverse Drug Reactions Bulletin 1998; 17:11.
18. Wysowski DK, Pitts M, Beitz J. Depression and suicide in patients treated with isotretinoin. New England Journal of Medicine 2001; 344:460.
19. Koo J. The psychosocial impact of acne: patients' perception. Journal of the American Academy of Dermatology 1995; 32:26-30.
20. Gupta MA, Gupta AK. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. British Journal of Dermatology 1998; 139:846-850.
21. Wu SF, Kinder BN, Trunnell TN, Fulton JE. Role of anxiety and anger in acne patients: a relationship with the severity of the disorder. Journal of the American Academy of Dermatology 1988; 18:325-333.
22. Cotterill JA, Cunliffe WJ. Suicide in dermatological patients. British Journal of Dermatology 1997; 137:246-250.
23. Krowchuk DP, Stancin T, Keskinen R, Walker R, Bass J, Anglin TM. The psychosocial effects of acne on adolescents. Pediatric Dermatology 1991; 8:332-338.
24. Kellett SC, Gawkrodger DJ. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. British Journal of Dermatology 1999; 140:273-282.
25. Rubinow DR, Peck GL, Squillace KM, Grantt GG. Reduced anxiety and depression in cystic acne patients after successful treatment with isotretinoin. Journal of the American Academy of' Dermatology 1987; 17:25-32.
26. Macdonald Hull S, Cunliffe WJ, Hughes BR. Treatment of the depressed and dysmorphophobic acne patient. Clinical and Experimental Dermatology 1991; 16:210-211.
27. Layton AM, Seukeron D, Cunliffe WJ. Scarred for life. Dermatology 1997; 195:29-33.
28. Peck GL, DiGiovanna JJ, Rubinow DR. Acute depression from isotretinoin, reply. Journal of the American Academy of Dermatology 1991; 25:132.
29. Jick SS, Kremers HM, Vasilakis-Scaramozza C. Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide. Archives of Dermatology 2000; 136:1231-1236.
30. Wysowski DK, Beitz J. Methodological limitations of the study 'Isotretinoin use and risk of depression, psychotic symptoms, suicide, and attempted suicide'. Archives of Dermatology 2001; 137:1102-1103.
31. Ng CH, Tam MM, Celi E, Tate B, Schweitzer I. A prospective study of depressive symptoms and quality of life in acne vulgaris patients treated with isotretinoin compared to antibiotic and topical therapy. Australasian Journal of Dermatology 2002; 43:262-268.
32. Wysowski DK, Pitts M, Beitz J. An analysis of reports of depression and suicide in patients treated with isotretinoin. Journal of the American Academy of Dermatology 2001; 45:515-519.
33. Henderson S, Andrews G, Hall W. Australia's mental health: an overview of the general population survey. Australian and New Zealand Journal of Psychiatry 2000; 34:197-205.
34. Patton GC, Coffey C, Posterino JB, Wolfe R. Adolescent depressive disorder: a population-based study of ICD- 10 symptoms. Australian and New Zealand Journal of Psychiatry 2000; 34:741-747.
35. Krezel W, Ghyselinck N, Samad TA et al. Impaired locomotion and dopamine signalling in retinoid receptor mutant mice. Science 1998; 279:863-867.
36. Peck GL, DiGiovanna JJ. The retinoids. In: Freedberg IM et al., eds. Fizpatrick's dermatology in general medicine, 5th edn. New York: McGraw-Hill, 1999; 2810-2820.
37. Feldman MH, Scglezinger NS. Benign intracranial hypertension associated with hypervitaminosis A. Achives of Neurology 1970; 22:1-7.
38. Byrne A, Costello M, Greene E, Zibin T. Isotretinoin therapy depression-evidence for an association. Irish Journal of Psychological Medicine 1998; 15:58-60.